A Rapid and Accurate Diagnostic Test for Influenza A & B Detection at the Point-of-Care
Flu is a highly contagious virus that targets your respiratory system. Unfortunately, flu is often mistaken for cold due to similar symptoms, making it very difficult for patients to receive proper diagnosis and treatment in time.
As flu season approaches, rapid and accurate testing has become essential to provide a timely diagnosis and help doctors make precise medical decisions on the spot. Hence, the influenza antiviral treatment can be indicated to provide the most benefit for patients within the first 48 hours of symptoms onset. Besides, an early influenza diagnosis and treatment also prevents the spreading of the virus to others.
VitaPCR™： Accurate Diagnostics, Whenever and Wherever You Need It.
Combining a simplified 1 minutes hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design without the need of extra equipment like refrigeration, and a proprietary RT-PCR technology allowing fast and accurate diagnostics; VitaPCR™ allows the detection of Influenza A & B virus in 20 minutes from sample to results, at the Point-of-Care.
VitaPCR™ empowers practitioners with the right information at the right time to make the right decision and provide the right course of treatment to the patients.
|
|
General Diagnostic Procedure
 |
 |
Intuitive Result Interpretation
| VitaPCR™ Flu A&B Assay | |
|---|---|
| Catalog No. | PCRAE0103 |
| Technology | rRT-PCR |
| Targets | M Gene - Influenza A NS Gene - Influenza B |
| Quantity | 20 tests/box |
| Sample Types | Nasal or Nasopharyngeal Swabs |
| Hands-on Time | < 1 min |
| Turnaround Time | 20 mins |
| Kit Storage | 5 - 25 °C / 41 - 77 °F |
Reference
-
Mboumba Bouassa RS, Tonen-Wolyec S, Rodary J, Bélec L. Comparative practicability and analytical performances of Credo VitaPCR™ Flu A&B and Cepheid Xpert® Xpress Flu/RSV platforms. Diagn Microbiol Infect Dis. 2021;100(4):115381